3 Underdog Stocks That Could Outperform the Market in the Second Half

Group 1: Market Overview - The S&P 500 index was up 5.5% by the midway point of 2025 and recently hit a new all-time high, raising questions about future growth amid uncertainties surrounding tariffs and trade policies [1] Group 2: UnitedHealth - UnitedHealth shares were down 38% as of the end of June, with a market cap reduced to around $275 billion from over $500 billion [4] - The stock is trading at 13 times trailing earnings, significantly lower than the S&P 500 average P/E of 24, suggesting potential undervaluation [5] - The company has withdrawn its guidance for the year due to rising costs, but there is potential for a positive earnings surprise in the latter half of the year [6][7] Group 3: Marvell Technology - Marvell Technology shares were down 30% at the half-year mark, with high growth expectations due to its application-specific integrated circuits (ASICs) used by hyperscalers [9] - The company reported $1.9 billion in revenue for the most recent quarter, a 63% year-over-year increase, indicating strong growth potential [10] - Marvell's forward P/E multiple of 27 is considered attractive compared to its historical averages, positioning it well in the AI market [11] Group 4: Deckers Outdoor - Deckers Outdoor shares were down 49% through the first six months of the year, impacted by exposure to China and economic challenges [12] - The company reported over $1 billion in quarterly sales, a 6% year-over-year increase, with net income rising by 19% to $151 million [13] - Trading at 17 times trailing earnings, Deckers is viewed as attractively priced for a growing business, with potential to outperform the S&P 500 in the second half [14]